Concepedia

George Mulligan

GM

Statistics

Publications

35

Citations

7.3K

H-Index

33

Active since

1990

Affiliations

Millennium Engineering and Integration (United States)(Current)

Mayo Clinic in Arizona

Dana-Farber Cancer Institute

Center for Cancer Research

Emory University

George Mulligan is an author at Millennium Engineering and Integration (United States) specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1990–2017

35

Publications

35

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Jonathan J. Keats, Rafaël Fonseca, Marta Chesi et al. · Cancer Cell · 2007 · 988 citations · Full text

, , +11

A subset of p53-deficient embryos exhibit exencephaly

Valerie P. Sah, Laura D. Attardi, George Mulligan et al. · Nature Genetics · 1995 · 580 citations

, , +12

Targeted disruption of the three Rb-related genes leads to loss of G<sub>1</sub> control and immortalization

Julien Sage, George Mulligan, Laura D. Attardi et al. · Genes & Development · 2000 · 579 citations · Full text

, , +15

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Shaji Kumar, Ian W. Flinn, Paul G. Richardson et al. · Blood · 2012 · 451 citations · Full text

, , +13

Shared role of the pRB-related p130 and p107 proteins in limb development.

David Cobrinik, M H Lee, Gregory J. Hannon et al. · Genes & Development · 1996 · 424 citations · Full text

, , +17

1–5 of 35